STAT3 activation underlies a host of tumorigenic cellular pathways, the foremost of which is in transcriptionally regulating glioma stem cells (GSCs)—a critically treatment-resistant population of cells that give rise to recurrent disease [54,55]. Here, STAT3 is linked to central nervous system cancer.